Lucira Health Inc's ROI from its third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Lucira Health Inc's ROI in the third quarter of 2022?
Lucira Health Inc recorded a cumulative net loss of $-143 million during 12 months ending in the third quarter of 2022, resulting in a negative return on investment (ROI) of -75.19%.

Within the Healthcare sector 838 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2022 from 0 to 4769.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter
Y / Y Investment Change TTM	-10.36 %	29.93 %	90.48 %	301.08 %	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	107	231	234	190	195
Return On Investment (TTM)	-75.19 %	-20.64 %	-18.39 %	-31.14 %	-34.91 %
LHDX's Overall Ranking	# 4769	# 0	# 0	# 0	# 0
Seq. Investment Change TTM	-10.42 %	1.8 %	0.38 %	-2.07 %	29.83 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-143	-44	-38	-65	-74

LHDX Company Profile >> Back to LHDX Roi Comparisons >> See Annual LHDX Return On Investment

Return On Investment LHDX's Ranking
Within:	No.
Industry	# 13
Sector	# 839
Overall	# 4769

Return On Investment Statistics
High	Average	Low
-18.39 %	-33.68 %	-75.19 %
(Mar 31 2022)		(Sep 30 2022)

Financial Statements
Lucira Health Inc's III. Quarter Investments	$ 107 Millions	LHDX's Balance sheet
Lucira Health Inc's III. Quarter Income	$ -127 Millions	Quarterly LHDX's Income Statement
LHDX's Income by Division		See LHDX's Income by Division

LHDX Annual Return On Investment	(Dec 31 2021) 2021
Total Investments in Millions	190	0	0	0	0
Y / Y Investment Growth	-	-	-	-	-
Net Income in Millions	-65	0	0	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-34.12 %	-	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
In Vitro & In Vivo Diagnostic Substances Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LHDX's Roi Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LHDX's Competitors
Subscribers only: Roi for Lucira Health Inc's Suppliers
Subscribers only: Return On Investment for LHDX's Customers

Other Ratios
LHDX's Roa	LHDX's Inventory Turnover Ratio	LHDX's Growth Rates	LHDX's Dividend Statistics
	LHDX's Profitability Ratios	LHDX's Asset Turnover Ratio	LHDX's Dividend Growth
LHDX's Roe	LHDX's Valuation Ratios	LHDX's Financial Strength Ratios	LHDX's Dividend Payout Ratio

Companies with similar Return On Investment at Sep 30 2022, within Healthcare Sector

ROI

Date modified: 2026-09-08T15:10:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.